珠海润都制药股份有限公司 关于公司参与国家组织集采药品协议期满品种接续 采购拟中选的公告

Core Viewpoint - Zhuhai Rundu Pharmaceutical Co., Ltd. has participated in the national organized procurement for drugs whose agreements are about to expire, and some of its products are expected to be selected in this procurement process [1]. Group 1: Selected Products - The products expected to be selected are from the first to the eighth batches of the national organized procurement agreements that are about to expire [1]. Group 2: Impact on the Company - The procurement cycle for the selected drugs will last from the actual execution date of the selection results until December 31, 2028 [1]. - Medical institutions will prioritize the use of the selected drugs during this procurement cycle, ensuring the completion of the agreed procurement volume [1]. - If procurement contracts are signed and implemented, it will further expand the sales volume of the products, increase market share, and enhance the company's brand image [1].